{"id":3188,"date":"2025-02-11T17:27:48","date_gmt":"2025-02-12T01:27:48","guid":{"rendered":"https:\/\/capca.ca\/document\/oral-cancer-drug-therapy-safe-use-and-safe-handling-guideline-2015\/"},"modified":"2025-04-10T01:37:13","modified_gmt":"2025-04-10T08:37:13","slug":"lignes-directrices-regissant-lutilisation-et-la-manipulation-securitaires-des-medicaments-oraux-pour-le-traitement-du-cancer","status":"publish","type":"document","link":"https:\/\/capca.ca\/fr\/document\/lignes-directrices-regissant-lutilisation-et-la-manipulation-securitaires-des-medicaments-oraux-pour-le-traitement-du-cancer\/","title":{"rendered":"Lignes directrices r\u00e9gissant l\u2019utilisation et la manipulation s\u00e9curitaires des m\u00e9dicaments oraux pour le traitement du cancer"},"content":{"rendered":"\n<div>\n<div class=\"capca-inner-container gb-element-34cfeac5\">\n<div class=\"gb-element-ce02219a\">\n<p class=\"wp-block-paragraph\">Les pr\u00e9sentes lignes directrices concernent particuli\u00e8rement le traitement du cancer par voie orale chez les adultes, mais nous croyons fermement qu\u2019elles peuvent s\u2019appliquer de mani\u00e8re g\u00e9n\u00e9rale et r\u00e9pondre \u00e0 d\u2019importants \u00e9carts et pr\u00e9occupations \u00e0 l\u2019\u00e9gard de l\u2019utilisation et de la manipulation s\u00e9curitaires de ces produits pharmaceutiques dangereux dans tous les milieux. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">L\u2019information requise par les patients devant subir un traitement du cancer par voie orale et leurs soignants, les pr\u00e9occupations li\u00e9es \u00e0 la sant\u00e9 et \u00e0 la s\u00e9curit\u00e9 au travail de leurs fournisseurs de soins de sant\u00e9, ainsi que l\u2019ensemble des craintes concernant la s\u00e9curit\u00e9 des patients demeurent les m\u00eames, quel que soit le milieu.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Les administrateurs et fournisseurs de soins \u0153uvrant dans les autres milieux recourant au traitement du cancer par voie orale, notamment les pharmacies communautaires, les soins \u00e0 domicile, les centres de traitement du cancer chez les enfants et les jeunes adultes, les \u00e9tablissements de soins de longue dur\u00e9e, les \u00e9tablissements carc\u00e9raux, les h\u00f4pitaux ainsi que les centres de jour et de soins de rel\u00e8ve, devraient examiner les pr\u00e9sentes lignes directrices afin de d\u00e9terminer la pertinence \u00e0 l\u2019\u00e9gard de leur milieu.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Par ailleurs, afin que toute la gamme de recommandations touchant l\u2019utilisation et la manipulation s\u00e9curitaires soit prise en consid\u00e9ration, le lecteur est tenu d\u2019utiliser le pr\u00e9sent document comme compl\u00e9ment et non comme document de reference.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/capca.ca\/wp-content\/uploads\/2025\/04\/Guideline-OACD2-General-2015-05-11-FR.pdf\">Voir les ressources<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Les pr\u00e9sentes lignes directrices concernent particuli\u00e8rement le traitement du cancer par voie orale chez les adultes, mais nous croyons fermement qu\u2019elles peuvent s\u2019appliquer de mani\u00e8re g\u00e9n\u00e9rale et r\u00e9pondre \u00e0 d\u2019importants \u00e9carts et pr\u00e9occupations \u00e0 l\u2019\u00e9gard de l\u2019utilisation et de la&#8230;<\/p>\n","protected":false},"template":"","meta":{"_acf_changed":true,"_crdt_document":"","_piecal_is_recurring":false,"_piecal_recurring_interval":1,"_piecal_recurring_frequency":"","_piecal_recurring_exact_position":false,"_piecal_recurring_end":"","_piecal_color":"","_piecal_text_color":"","_piecal_global_color_master":false,"_piecal_rsets":"[]","_piecal_is_event":false,"_piecal_start_date":"","_piecal_end_date":"","_piecal_is_allday":false,"inline_featured_image":false},"document-cancer-site":[],"document-capca-initiative":[198],"document-resource-type":[175],"document-topic":[181],"document-treatment-modality":[192],"featured-item":[],"class_list":["post-3188","document","type-document","status-publish","hentry","document-capca-initiative-autre","document-resource-type-document-dorientation-consensuel","document-topic-qualite-et-securite","document-treatment-modality-traitement-oral-contre-le-cancer"],"acf":[],"_links":{"self":[{"href":"https:\/\/capca.ca\/fr\/wp-json\/wp\/v2\/document\/3188","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/capca.ca\/fr\/wp-json\/wp\/v2\/document"}],"about":[{"href":"https:\/\/capca.ca\/fr\/wp-json\/wp\/v2\/types\/document"}],"wp:attachment":[{"href":"https:\/\/capca.ca\/fr\/wp-json\/wp\/v2\/media?parent=3188"}],"wp:term":[{"taxonomy":"document-cancer-site","embeddable":true,"href":"https:\/\/capca.ca\/fr\/wp-json\/wp\/v2\/document-cancer-site?post=3188"},{"taxonomy":"document-capca-initiative","embeddable":true,"href":"https:\/\/capca.ca\/fr\/wp-json\/wp\/v2\/document-capca-initiative?post=3188"},{"taxonomy":"document-resource-type","embeddable":true,"href":"https:\/\/capca.ca\/fr\/wp-json\/wp\/v2\/document-resource-type?post=3188"},{"taxonomy":"document-topic","embeddable":true,"href":"https:\/\/capca.ca\/fr\/wp-json\/wp\/v2\/document-topic?post=3188"},{"taxonomy":"document-treatment-modality","embeddable":true,"href":"https:\/\/capca.ca\/fr\/wp-json\/wp\/v2\/document-treatment-modality?post=3188"},{"taxonomy":"featured-item","embeddable":true,"href":"https:\/\/capca.ca\/fr\/wp-json\/wp\/v2\/featured-item?post=3188"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}